Recently, 'Kongshanci', a company dedicated to the advancement of non-invasive brain-computer interfaces and neuromodulation technologies, has successfully closed its Pre-A funding round. This financing initiative was exclusively spearheaded by Yunqi Capital. The infusion of capital will be strategically allocated towards bolstering core technology R&D, facilitating clinical translation efforts, and fueling global market expansion.

It has been reported that Kongshanci harnesses cutting-edge multi-dimensional brain signal analysis techniques, employing modulation methods spanning ultrasound, magnetic fields, electricity, and light. By seamlessly integrating AI technology, the company has engineered an intelligent management system that permeates the entire spectrum of diagnosis, treatment, and patient care. This innovative approach culminates in a technological closed-loop system, enabling the continuous refinement of clinical data and intervention strategies. Ultimately, this paves the way for the construction of a next-generation, full-stack technology platform that is finely tuned to meet the evolving demands of brain science research and application.